Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): A systematic literature review

Clinical Medicine Insights: Cardiology

Volumn 7, Issue , 2013, Pages 97-114

  Romero, Jorge ^a   Mejia Lopez, Eeliany ^a   Manrique, Carlos ^a   Lucariello, Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy (ARVC D); Cardiomyopathy; Sudden cardiac death; Tachyarrhythmias

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DESMOPLAKIN; SOTALOL; TRANSFORMING GROWTH FACTOR ALPHA; VERAPAMIL;

ANEURYSM RUPTURE; ANGIOGRAPHY; ARTICLE; ASYMPTOMATIC DISEASE; CARDIAC RYANODINE 2 GENE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DESMOPLAKIN GENE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EXERCISE; GENE; GENETIC ANALYSIS; GENETIC SCREENING; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE DYSPLASIA; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; JUNCTION PLAKOGLOBIN GENE; MOLECULAR PATHOLOGY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHYSICAL ACTIVITY; PREVALENCE; RADIOFREQUENCY ABLATION; RADIOISOTOPE VENTRICULOGRAPHY; RIGHT VENTRICULAR ANGIOGRAPHY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SYSTEMATIC REVIEW; TRANSFORMING GROWTH FACTOR ALPHA GENE;

EID: 84878195274     PISSN: 11795468     EISSN: None     Source Type: Journal    
DOI: 10.4137/CMC.S10940     Document Type: Article

References (132)

1. Blomstrom-Lundqvist C, Sabel KG, Olsson SB. A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J. 1987;58(5):477-88.
2. Manyari DE, Klein GJ, Gulamhusein S, etal. Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy? Circulation. 1983;68(2): 251-7.
3. Pinamonti B, Sinagra G, Salvi A, etal. Left ventricular involvement in right ventricular dysplasia. Am Heart J. 1992;123(3):711-24.
4. Webb JG, Kerr CR, Huckell VF, Mizgala HF, Ricci DR. Left ventricular abnormalities in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 1986;58(6):568-70.
5. Fontaine G, Frank R, Fontaliran F, Lascault G, Tonet J. Right ventricular tachycardias. In: Parmley WW, Chatterjee K, eds. Cardiology. New York, NY: JB Lippincott Co; 1992:1-17.
6. Lancisi G. De Motu Cordis et Aneurysmatibus Opus Posthumum In Duas Partes Divisum. Rome: Giovanni Maria Salvioni; 1728.
7. Marcus FI, Fontaine GH, Guiraudon G, etal. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384-98.
8. Fontaine G, Frank R, Guiraudon G, etal. Significance of intraventricular conduction disorders observed in arrhythmogenic right ventricular dysplasia. Arch Mal Coeur Vaiss. 1984;77(8):872-9.
9. Thiene G, Basso C, Danieli G, Rampazzo A, Corrado D, Nava A. Arrhythmogenic right ventricular cardiomyopathy a still underrecognized clinic entity. Trends Cardiovasc Med. 1997;7(3):84-90.
10. Dungan WT, Garson A Jr, Gillette PC. Arrhythmogenic right ventricular dysplasia: a cause of ventricular tachycardia in children with apparently normal hearts. Am Heart J. 1981;102(4):745-50.
11. Foale RA, Nihoyannopoulos P, Ribeiro P, etal. Right ventricular abnormalities in ventricular tachycardia of right ventricular origin: relation to electrophysiological abnormalities. Br Heart J. 1986;56(1):45-54.
12. Fontaine G, Frank R, Tonet JL, etal. Arrhythmogenic right ventricular dysplasia: a clinical model for the study of chronic ventricular tachycardia. Jpn Circ J. 1984;48(6):515-38.
13. Halphen C, Beaufils P, Azancot I, Baudouy P, Manne B, Slama R. Recurrent ventricular tachycardia due to right ventricular dysplasia. Association with left ventricular anomalies. Arch Mal Coeur Vaiss. 1981;74(9):1113-8.
14. Lemery R, Brugada P, Janssen J, Cheriex E, Dugernier T, Wellens HJ. Nonischemic sustained ventricular tachycardia: clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol. 1989;14(1):96-105.
15. Martini B, Nava A, Thiene G, etal. Monomorphic repetitive rhythms originating from the outflow tract in patients with minor forms of right ventricular cardiomyopathy. Int J Cardiol. 1990;27(2):211-21.
16. Martini B, Nava A, Thiene G, etal. Accelerated idioventricular rhythm of infundibular origin in patients with a concealed form of arrhythmogenic right ventricular dysplasia. Br Heart J. 1988;59(5):564-71.
17. Mehta D, Odawara H, Ward DE, McKenna WJ, Davies MJ, Camm AJ. Echocardiographic and histologic evaluation of the right ventricle in ventricular tachycardias of left bundle branch block morphology without overt cardiac abnormality. Am J Cardiol. 1989;63(13):939-44.
18. Nava A, Canciani B, Daliento L, etal. Juvenile sudden death and effort ventricular tachycardias in a family with right ventricular cardiomyopathy. Int J Cardiol. 1988;21(2):111-26.
19. Rossi P, Massumi A, Gillette P, Hall RJ. Arrhythmogenic right ventricular dysplasia: clinical features, diagnostic techniques, and current management. Am Heart J. 1982;103(3):415-20.
20. Rowland E, McKenna WJ, Sugrue D, Barclay R, Foale RA, Krikler DM. Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features. Br Heart J. 1984;51(1):15-24.
21. Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation. 2006; 113(13):1634-7.
22. Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2001;38(7):1773-81.
23. Dalal D, Nasir K, Bomma C, etal. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation. 2005;112(25):3823-32.
24. Corrado D, Fontaine G, Marcus FI, etal. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation. Circulation. 2000;101(11):E101-6.
25. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339(6):364-9.
26. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318(3): 129-33.
27. Shen WK, Edwards WD, Hammill SC, Gersh BJ. Right ventricular dysplasia: a need for precise pathological definition for interpretation of sudden death. Am Coll Cardiol. 1994;23:34A.
28. McKoy G, Protonotarios N, Crosby A, etal. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000; 355(9221):2119-24.
29. Cheng TO. Ethnic differences in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Int J Cardiol. 2002;83(3):293; author reply 291.
30. Uhl H. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp. 1952;91:197-209.
31. Wager GP, Couser RJ, Edwards OP, Gmach C, Bessinger B Jr. Antenatal ultrasound findings in a case of Uhl's anomaly. Am J Perinatol. 1988;5(2):164-7.
32. Gerlis LM, Schmidt-Ott SC, Ho SY, Anderson RH. Dysplastic conditions of the right ventricular myocardium: Uhl's anomaly vs. arrhythmogenic right ventricular dysplasia. Br Heart J. 1993;69(2):142-50.
33. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94(5):983-91.
34. Richardson P, McKenna W, Bristow M, etal. Report of the 1995World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93(5):841-2.
35. McKenna WJ, Thiene G, Nava A, etal. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71(3):215-8.
36. Miani D, Pinamonti B, Bussani R, Silvestri F, Sinagra G, Camerini F. Right ventricular dysplasia: a clinical and pathological study of two families with left ventricular involvement. Br Heart J. 1993;69(2):151-7.
37. Nava A, Thiene G, Canciani B, etal. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol. 1988;12(5):1222-8.
38. Calabrese F, Basso C, Carturan E, Valente M, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc Pathol. 2006;15(1):11-7.
39. Bowles NE, Ni J, Marcus F, Towbin JA. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2002;39(5):892-5.
40. Thiene G, Corrado D, Nava A, etal. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? Eur Heart J. 1991;12(Suppl D): 22-5.
41. Fontaliran F, Fontaine G, Brestescher C, Labrousse J, Vilde F. Significance of lymphoplasmocytic infiltration in arrhythmogenic right ventricular dysplasia. Apropos of 3 own cases and review of the literature. Arch Mal Coeur Vaiss. 1995;88(7):1021-8.
42. Warnes CD, J. Congenital Heart disease in adults. In: Fuster V, Alexander W, O'Rourke RA, editors. Hurst's, The Heart, 10th ed. New York: Mcgraw-Hill; 2000:1800-1801.
43. Coonar AS, Protonotarios N, Tsatsopoulou A, etal. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation. 1998;97(20):2049-58.
44. Rampazzo A, Nava A, Erne P, etal. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet. 1995;4(11):2151-4.
45. Severini GM, Krajinovic M, Pinamonti B, etal. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics. 1996;31(2):193-200.
46. Rampazzo A, Nava A, Malacrida S, etal. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002;71(5):1200-6.
47. Dalal D, Molin LH, Piccini J, etal. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation. 2006;113(13):1641-9.
48. van Tintelen JP, Entius MM, Bhuiyan ZA, etal. Plakophilin-2mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2006;113(13):1650-8.
49. Awad MM, Dalal D, Cho E, etal. DSG2mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet. 2006;79(1):136-42.
50. Pilichou K, Nava A, Basso C, etal. Mutations in desmoglein-2gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113(9):1171-9.
51. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115(13):1710-20.
52. Gerull B, Heuser A, Wichter T, etal. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36(11):1162-4.
53. Norgett EE, Hatsell SJ, Carvajal-Huerta L, etal. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet. 2000;9(18):2761-6.
54. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289-300.
55. Beffagna G, Occhi G, Nava A, etal. Regulatory mutations in transforming growth factor-beta3gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005;65(2):366-73.
56. Merner ND, Hodgkinson KA, Haywood AF, etal. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 2008;82(4):809-21.
57. Tiso N, Stephan DA, Nava A, etal. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10(3):189-94.
58. Nasir K, Bomma C, Tandri H, etal. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation. 2004;110(12): 1527-34.
59. Thiene G, Basso C. Arrhythmogenic right ventricular cardiomyopathy: An update. Cardiovasc Pathol. 2001;10(3):109-17.
60. Corrado D, Basso C, Thiene G, etal. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30(6):1512-20.
61. Nava A, Thiene G, Canciani B, etal. Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmias. Int J Cardiol. 1992;35(2):195-206; discussion 207-9.
62. Daliento L, Turrini P, Nava A, etal. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol. 1995;25(3):655-64.
63. Martini B, Basso C, Thiene G. Sudden death in mitral valve prolapse with Holter monitoring-documented ventricular fibrillation: evidence of coexisting arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol. 1995;49(3):274-8.
64. Cubero JM, Gallego P, Pavon M. Arrhythmogenic right ventricular cardiomyopathy and atrial right-to-left shunt. Acta Cardiol. 2002;57(6):443-5.
65. Hagenah G, Andreas S, Konstantinides S. Accidental left ventricular placement of a defibrillator probe due to a patent foramen ovale in arrhythmogenic right ventricular dysplasia. Acta Cardiol. 2004;59(4):449-51.
66. Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol. 2005;14(1):37-41.
67. Niroomand F, Carbucicchio C, Tondo C, etal. Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia. Heart. 2002;87(1):41-7.
68. Fontaliran F, Fontaine G, Fillette F, Aouate P, Chomette G, Grosgogeat Y. Nosologic frontiers of arrhythmogenic dysplasia. Quantitative variations of normal adipose tissue of the right heart ventricle. Arch Mal Coeur Vaiss. 1991;84(1):33-8.
69. Lobo FV, Heggtveit HA, Butany J, Silver MD, Edwards JE. Right ventricular dysplasia: morphological findings in 13 cases. Can J Cardiol. 1992;8(3): 261-8.
70. Angelini A, Basso C, Nava A, Thiene G. Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. Am Heart J. 1996;132(1 Pt 1):203-6.
71. Manyari DE, Duff HJ, Kostuk WJ, etal. Usefulness of noninvasive studies for diagnosis of right ventricular dysplasia. Am J Cardiol. 1986;57(13): 1147-53.
72. Marcus FI, McKenna WJ, Sherrill D, etal. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 2010;121(13):1533-41.
73. Basso C, Wichter T, Danieli GA, etal. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J. 2004;25(6):531-4.
74. Marcus F, Towbin JA, Zareba W, etal. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation. 2003;107(23):2975-8.
75. Hamid MS, Norman M, Quraishi A, etal. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol. 2002;40(8):1445-50.
76. Syrris P, Ward D, Asimaki A, etal. Clinical expression of plakophilin-2mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113(3):356-64.
77. Jaoude SA, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. Eur Heart J. 1996;17(11):1717-22.
78. Nava A, Bauce B, Basso C, etal. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2000;36(7):2226-33.
79. Cox MG, Nelen MR, Wilde AA, etal. Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria. J Cardiovasc Electrophysiol. 2008;19(8):775-81.
80. Fontaine G, Umemura J, Di Donna P, Tsezana R, Cannat JJ, Frank R. Duration of QRS complexes in arrhythmogenic right ventricular dysplasia. A new non-invasive diagnostic marker. Ann Cardiol Angeiol (Paris). 1993; 42(8):399-405.
81. Kamath GS, Zareba W, Delaney J, etal. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/Heart Rhythm. 2011;8(2):256-62.
82. Tandri H, Saranathan M, Rodriguez ER, etal. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45(1):98-103.
83. Schionning JD, Frederiksen P, Kristensen IB. Arrhythmogenic right ventricular dysplasia as a cause of sudden death. Am J Forensic Med Pathol. 1997;18(4):345-8.
84. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110(14):1879-84.
85. Sen-Chowdhry S, Lowe MD, Sporton SC, McKenna WJ. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med. 2004;117(9):685-95.
86. Smith W. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Heart Lung Circ. 2011;20(12):757-60.
87. Epstein AE, DiMarco JP, Ellenbogen KA, etal. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350-408.
88. Wichter T, Breithardt G. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making? J Am Coll Cardiol. 2005;45(3):409-11.
89. Zipes DP, Camm AJ, Borggrefe M, etal. ACC/AHA/ESC 2006guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48(5): e247-346.
90. Marcus FI, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J. 1989;10(Suppl D):68-73.
91. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation. 1992;86(1):29-37.
92. Hauer RN, Aliot E, Block M, etal. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J. 2001;22(13):1074-81.
93. Corrado D, Leoni L, Link MS, etal. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108(25): 3084-91.
94. Fornes P, Ratel S, Lecomte D. Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia-an autopsy study of 20 forensic cases. J Forensic Sci. 1998;43(4):777-83.
95. Leclercq JF, Potenza S, Maison-Blanche P, Chastang C, Coumel P. Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol. 1996;28(3):720-4.
96. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005;45(8):1340-5.
97. Furlanello F, Bertoldi A, Dallago M, etal. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol. 1998;21(1 Pt 2):331-5.
98. Burke AP, Robinson S, Radentz S, Smialek J, Virmani R. Sudden death in right ventricular dysplasia with minimal gross abnormalities. J Forensic Sci. 1999;44(2):438-43.
99. Steinberg JS, Martins J, Sadanandan S, etal. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Am Heart J. 2001;142(3):520-9.
100. Leclercq JF, Coumel P. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia. Eur Heart J. 1989; 10(Suppl D):61-7.
101. Reiter MJ, Reiffel JA. Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol. 1998;82(4A):9I-19I.
102. Marcus GM, Glidden DV, Polonsky B, etal. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol. 2009;54(7):609-15.
103. Corrado D, Calkins H, Link MS, etal. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation. 2010;122(12):1144-52.
104. Hodgkinson KA, Parfrey PS, Bassett AS, etal. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol. 2005;45(3):400-8.
105. Zwanziger J, Hall WJ, Dick AW, etal. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47(11): 2310-8.
106. Link MS, Wang PJ, Haugh CJ et al. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. Jinterv Card Electrophysiol. 1997;1:41.
107. Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Int J Cardiol. 2006;107(3):360-8.
108. Roguin A, Bomma CS, Nasir K, etal. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004;43(10):1843-52.
109. Tavernier R, Gevaert S, De Sutter J, etal. Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart. 2001;85(1):53-6.
110. Wichter T, Paul M, Wollmann C, etal. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation. 2004;109(12):1503-8.
111. [No authors listed]. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337(22):1576-83.
112. Connolly SJ, Gent M, Roberts RS, etal. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101(11):1297-302.
113. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102(7):748-54.
114. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994;127(4 Pt 2):1139-44.
115. Bhonsale A, James CA, Tichnell C, etal. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol. 2011;58(14):1485-96.
116. Maisel WH, Moynahan M, Zuckerman BD, etal. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295(16):1901-6.
117. Pfeiffer D, Jung W, Fehske W, etal. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J. 1994;127(4 Pt 2): 1073-80.
118. Passman R, Subacius H, Ruo B, etal. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med. 2007;167(20): 2226-32.
119. Schron EB, Exner DV, Yao Q, etal. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5): 589-94.
120. Moss AJ, Schuger C, Beck CA, etal. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24): 2275-83.
121. Wilkoff BL, Williamson BD, Stern RS, etal. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52(7):541-50.
122. Dorian P, Philippon F, Thibault B, etal. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm. 2004;1(5):540-7.
123. Swerdlow CD, Gunderson BD, Ousdigian KT, etal. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation. 2008;118(21):2122-9.
124. Dalal D, Jain R, Tandri H, etal. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2007;50(5):432-40.
125. Fontaine G, Tonet J, Gallais Y, etal. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr Cardiol Rep. 2000;2(6):498-506.
126. Marchlinski FE, Zado E, Dixit S, etal. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation. 2004;110(16):2293-8.
127. Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2009;120(5):366-75.
128. Damiano RJ Jr, Asano T, Smith PK, Cox JL. Effect of the right ventricular isolation procedure on ventricular vulnerability to fibrillation. J Am Coll Cardiol. 1990;15(3):730-6.
129. Guiraudon GM, Klein GJ, Gulamhusein SS, etal. Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation. 1983;67(2):463-70.
130. Guiraudon GM, Klein GJ, Sharma AD, Yee R, Guiraudon CM. Surgical therapy for arrhythmogenic right ventricular adiposis. Eur Heart J. 1989; 10(Suppl D):82-3.
131. Thiene G, Angelini A, Basso C, Calabrese F, Valente M. Novel heart diseases requiring transplantation. Adv Clin Path. 1998;2(1):65-73.
132. Quarta G, Muir A, Pantazis A, etal. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123(23):2701-9.